Department of Respiratory Medicine, P.D. Hinduja Hospital and Medical Research Centre, Mumbai, India.
Department of Critical Care Medicine, P.D. Hinduja Hospital and Medical Research Centre, Mumbai, India.
Chest. 2022 Apr;161(4):e213-e217. doi: 10.1016/j.chest.2021.11.024.
A 58-year-old man presented to us with a 1-week history of high-grade fever and progressive dry cough. Four weeks before his presentation, he was diagnosed with COVID-19 infection and needed non-ICU hospital admission with no supplemental oxygen requirements for 6 days and was treated with a 5-day course of remdesivir and 3 weeks of dexamethasone. His steroid dose was commenced on dexamethasone 12 mg bid (four times the recommended dose) for 14 days and then gradually tapered over the remaining 7 days. His history was unremarkable, except for well-controlled asthma. He did not complain of any shortness of breath, weight loss, or loss of appetite. He was never a smoker and denied any alcohol use.
一位 58 岁男性因高热和进行性干咳 1 周就诊。在他就诊前 4 周,他被诊断为 COVID-19 感染,无需补充氧气,非 ICU 住院 6 天,并接受了 5 天的瑞德西韦和 3 周的地塞米松治疗。他的类固醇剂量从地塞米松 12mg bid(推荐剂量的四倍)开始,共 14 天,然后在剩余的 7 天内逐渐减少。他的病史无特殊,除了控制良好的哮喘。他没有呼吸困难、体重减轻或食欲不振的症状。他从不吸烟,也不饮酒。